Cargando…
Inhibition of glutathione metabolism attenuates esophageal cancer progression
Esophageal squamous cell carcinoma (ESCC) is a deadly malignancy with regard to mortality and prognosis, and the 5-year survival rate for all patients diagnosed with ESCC remains poor. A better understanding of the biological mechanisms of ESCC tumorigenesis and progression is of great importance to...
Autores principales: | Peng, Liang, Linghu, Ruixia, Chen, Demeng, Yang, Jing, Kou, Xiaoxue, Wang, Xiang-Zhen, Hu, Yi, Jiang, Yi-Zhou, Yang, Junlan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130218/ https://www.ncbi.nlm.nih.gov/pubmed/28428633 http://dx.doi.org/10.1038/emm.2017.15 |
Ejemplares similares
-
Ubiquitin specific protease 21 upregulation in breast cancer promotes cell tumorigenic capability and is associated with the NOD-like receptor signaling pathway
por: Peng, Liang, et al.
Publicado: (2016) -
Breast carcinoma with choriocarcinomatous features: a case report and review of the literature
por: Zhu, Yanyun, et al.
Publicado: (2014) -
Glutathione Metabolism in Renal Cell Carcinoma Progression and Implications for Therapies
por: Xiao, Yi, et al.
Publicado: (2019) -
Docetaxel/S-1 Versus Docetaxel/Capecitabine as First-Line Treatment for Advanced Breast Cancer: A Retrospective Study
por: Li, Jinyu, et al.
Publicado: (2015) -
Blocking glycine utilization inhibits multiple myeloma progression by disrupting glutathione balance
por: Xia, Jiliang, et al.
Publicado: (2022)